Company: Stryker Corporation
Ticker: SYK
Form: 10-K
Filed: 2026-02-11
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Stryker Corporation's total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 47844.0
Answer (Display): $47,844 million
Unit: USD millions

Evidence:
[{"chunk_id": "137", "equivalent_chunk_ids": ["137"], "section": "Consolidated Balance Sheets.", "supports": ["main"], "text": "2,265\nSegment operating income\n7,492\n6,595\n5,735\nItems not allocated to segments:\nCorporate and Other\nInventory stepped up to fair value\nAcquisition and integration-related charges\nAmortization of intangible assets\nStructural optimization and other special\ncharges\nGoodwill and other impairments\nMedical device regulation\nRecall-related matters\nRegulatory and legal matters\nConsolidated operating income\n4,889\n3,689\n3,888\nSegment Assets and Capital Spending\nAssets:\nMedSurg and Neurotechnology\n27,647\n23,115\nOrthopaedics\n18,641\n18,507\nTotal segment assets\n46,288\n41,622\nCorporate and Other\n1,556\n1,349\nTotal assets\n47,844\n42,971\nPurchases of property, plant and\nequipment:\nOrthopaedics\nMedSurg and Neurotechnology\nTotal segment purchases of property,\nplant and equipment\nCorporate and Other\nTotal purchases of property, plant and\nequipment\nWe measure the financial results of our reportable segments\nusing an internal performance measure that excludes acquisition\nand integration-related charges, structural optimization and other\nspecial charges, goodwill and other impairments, reserves for\ncertain product recall matters and reserves for certain legal and\nregulatory matters. Identifiable assets are those assets used\nexclusively in the operations of each business segment or\nallocated when used jointly. Corporate assets are principally\nDollar amounts in millions except per share amounts or as otherwise specified.\nSTRYKER CORPORATION\nFORM 10-K\nproperty, plant and equipment and noncurrent assets.\nThe countries in which we have local revenue generating\noperations have been combined into the following geographic\nareas: the United States; Europe, Middle East, Africa; Asia\nPacific; and other foreign countries, which include Canada and\ncountries in the Latin American region. Net sales are reported\nbased on the geographic area of the Stryker location where the\nsales to the customer originated.\nGeographic Information\nNet Sales\nNet Property, Plant\nand Equipment\nUnited States\n19,006\n16,943\n15,257\n2,084\n1,997\nEurope, Middle\nEast, Africa\n3,181\n2,897\n2,618\n1,562\n1,260\nAsia Pacific\n2,164\n2,020\n1,946\nOther countries\nTotal\n25,116\n22,595\n20,498\n3,876\n3,448\nNOTE 15 -\nASSET IMPAIRMENTS\nDuring\nand\nwe recorded impairment charges of\nand\nto write off long-lived and intangible assets\nexcluding long-lived assets held for sale which included charges\nrelated to certain product line exits\nOTE 16 -\nSALE OF SPINAL IMPLANTS BUSINESS\nDuring the fourth quarter 2024 management committed to a plan\nto sell certain assets associated with the Spinal Implants\nbusiness (disposal group) and such assets were classified as\nheld for sale beginning November 2024. As a result we recorded\na valuation allowance of\nto record the disposal group at its"}]

Derivation: